Developing tools to combat infectious diseases and prepare for pandemics
Official title: UofL RBL Operations, Workforce Development and Pandemic Preparedness Research
Funded at University of Louisville · NIH-10910200 · Data updated 2026-11-12
This study is all about making better tests, treatments, and vaccines for new infectious diseases, like COVID-19, so that we can be more prepared for future health crises, and it aims to help patients by improving how we prevent and treat these illnesses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $2,667,645 |
| NIH project number | 5UC7AI180309-02 |
| Project ID | NIH-10910200 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include individuals affected by or at risk for infectious diseases, particularly those related to COVID-19.
✕Less likely to help
Patients with non-infectious diseases or those not impacted by emerging infectious diseases may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing the capabilities of the University of Louisville Regional Biocontainment Laboratory to develop diagnostics, therapeutics, and vaccines aimed at addressing emerging infectious diseases, particularly in response to public health crises like COVID-19. The laboratory operates specialized facilities designed for high-risk pathogens, allowing for safe and effective research. By leveraging past experiences with pandemics and biological threats, the research aims to improve preparedness and response strategies for future outbreaks. Patients may benefit from advancements in treatment and prevention methods that arise from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostics and treatments for infectious diseases, enhancing public health safety.
How similar studies have gone: Previous research in biocontainment and pandemic preparedness has shown success in developing effective responses to infectious disease outbreaks.
Where this research is happening
-
University of Louisville
Louisville, United States Active
Researchers
- Principal investigator: Palmer, Kenneth E — University of Louisville
- Study coordinator: Palmer, Kenneth E
Related research
Other NIH-funded projects on the same topics.
-
Gastric rhythm map to understand stomach problems using a new noninvasive tool
A new noninvasive body surface mapping method is being tested to see if abnormal stomach electrical rhythms explain chronic stomach problems like functional dyspepsia and persistent nausea.
-
Novel antivirals for alphavirus arthritis
A research team is refining a promising antiviral compound to treat alphavirus infections that cause arthritis, with a focus on Chikungunya and related viruses.
-
Linking heavy metal exposure to a tougher breast cancer type (TNBC)
Aimed at understanding how heavy metals like cadmium might trigger a dangerous breast cancer type (TNBC) in people, especially those with BRCA1 risk, to identify possible future treatment strategies.
-
Cardiac safety of flavored e-cigarette aerosols in adults
A pharmacist or clinician would test how inhaling flavored e-cigarette aerosols affects heart rhythm in adults to see if flavors raise the risk of heart problems.
-
Biomedical Research Facilities to Expand Precision Medicine in Kentucky
A large NIH grant aims to renovate and expand a shared precision medicine center in Kentucky to speed up research that could improve health for people in Appalachia and surrounding areas.
-
Rac-enhanced CAR-Macrophages against TNBC
A new cell therapy approach uses engineered macrophages with a CAR and Rac2 activation to target and kill triple-negative breast cancer cells expressing CSPG4.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.